Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
T. Planté-Bordeneuve (Brussels, Belgium), C. Pilette (Brussels, Belgium), Y. Yakoub (Brussels, Belgium), M. Lecocq (Brussels, Belgium), F. Huaux (Brussels, Belgium), A. Froidure (Brussels, Belgium). The pIgR-IgA system as a new player in lung fibrosis. 867

Member's Comments

No comment yet.

Related content which might interest you: The pathomechanistic role of autophagy in lung fibrosis Source: International Congress 2017 – Interstitial lung diseases (ILDs): novel pathogenetic pathways Year: 2017 Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis Source: Eur Respir J 2015; 46: 1084-1094 Year: 2015 Identifying pulmonary hypertension in newly recognized interstitial lung diseases – a role of new scoring system Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases Year: 2020 The role of apoptosis in pulmonary fibrosis Source: Eur Respir Rev 2008; 17: 138-144 Year: 2008 Growth factor regulation of lung fibrosis lessons from other organs Source: Annual Congress 2006 - Scientific year in review Year: 2006 αB-crystallin is involved in the process of pulmonary fibrosis Source: Annual Congress 2011 - The ageing pulmonary interstitium Year: 2011 αB-crystallin is involved in the process of pulmonary fibrosis Source: Annual Congress 2010 - Emerging mechanisms in lung injury Year: 2010 Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology Source: Eur Respir J 2010; 35: 496-504 Year: 2010 KCa3.1 channel inhibition prevents fibrotic responses in a human lung explant model Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 The central role of CFTR in lung disease Source: International Congress 2016 – What can respiratory medicine learn from cystic fibrosis research? Year: 2016 Epithelial pIgR: A new player in idiopathic pulmonary fibrosis? Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 PBI-4050 reduces expression of fibrosis biomarkers in the BioMAP SAEMyoF primary human small airway epithelial cells and lung myofibroblasts system Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 LSC Abstract – A human lung explant model of fibrogenesis for the assessment of anti-fibrotic strategies in idiopathic pulmonary fibrosis Source: International Congress 2016 – Molecular immunology of the lung Year: 2016 The role of extracellular vesicles in phenotypic alteration of lung cells in pulmonary fibrosis Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury Year: 2013 Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases Year: 2011 Apoptosis in lung injury and fibrosis Source: Eur Respir J 2008; 32: 1631-1638 Year: 2008 The pathogenesis of pulmonary fibrosis: a moving target Source: Eur Respir J 2013; 41: 1207-1218 Year: 2013